These cases highlight the clinical and laboratory heterogeneity of type IIB von Willebrand disease, particularly the possibility of de novo mutations or variable penetrance given the lack of family history.
Answers are grounded in this paper and cite their sources.
Supports heterogeneity in type IIB VWD without family history; leaves open de novo mutations or penetrance for genetic studies.
Two patients from two separate families were diagnosed as having type IIB von Willebrand disease, because they had lifelong bleeding tendencies, prolonged bleeding times, no large von Willebrand factor multimers, and low levels of ristocetin cofactor in plasma with heightened ristocetin-induced platelet aggregation. There was no history of bleeding, and no laboratory abnormalities were found in the parents and sibship of either propositi, in contrast with the autosomal dominant pattern of inheritance usually observed in type IIB von Willebrand disease. Abnormalities of ristocetin-induced von Willebrand factor-platelet interactions were less severe than in a patient from a previously reported family with type IIB von Willebrand disease studied in parallel. The peculiar features of these cases provide additional evidence of the existence of heterogeneity within this variant.
No takes yet. Share an insight, caveat, or question.
Federici et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: